Are Gujarati Asian Indians older for their vascular age as compared to their Chronological age?

Size: px
Start display at page:

Download "Are Gujarati Asian Indians older for their vascular age as compared to their Chronological age?"

Transcription

1 Q J Med 2015; 108: doi: /qjmed/hcu158 Advance Access Publication 1 August 2014 Are Gujarati Asian Indians older for their vascular age as compared to their Chronological age? K.H. SHARMA, S. SAHOO, K.H. SHAH, A.K. PATEL, N.D. JADHAV, M.M. PARMAR and K.H. PATEL From the U. N. Mehta Institute of Cardiology and Research Centre (UNMICRC), Asarwa, Ahmedabad, , India Address correspondence to K.H. Sharma, Department of Cardiology, U. N. Mehta Institute of Cardiology and Research Centre, Civil Hospital Campus, Ahmedabad , Gujarat, India. kamalsharma1975@gmail.com Received 19 June 2014 and in revised form 23 July 2014 Summary Background: South Asians are known to carry higher burden of cardiovascular diseases when compared with their Caucasian counterparts. Aim: This study was designed to evaluate whether vascular age is advanced for Gujarati Asian Indians as matched to their chronological age in apparently healthy, asymptomatic population. We have also assessed the contributing risk factors for premature vascular ageing. Design: It was cross-sectional study of 2483 individuals of Gujarat state in Western India having no past or present history of major illness including cardiovascular diseases. Method: The vascular age of the population was calculated using Framingham vascular age calculator. A relationship between risk factor prevalence and vascular ageing was evaluated using univariate analysis of variance. Results: The mean chronological age of the study population was 46.8 (10.35) years whereas mean Introduction Cardiovascular diseases (CVD) including coronary artery disease (CAD) and stroke, are leading cause of mortality and morbidity in the developing countries of the world. 1 The origin of emerging CVD risks in Indians lies in epidemic transition which is a result of affluence, urbanization and vascular age was (16.05) years, and the difference ( ) between both was statistically significant (P < ). Contributory risk factors for advanced vascular age apart from chronological age (75.4%) and male gender (66.2%) were the presence of dyslipidemia (60.4%) hypertension (57.34%) and increased waist circumference (WC) (male 39.7%, female 29%). Results of regression analysis showed that vascular age progression was highly associated with blood pressure (19.9, 95% CI: ), followed by smoking (15.23, 95% CI: ), and blood sugar (12.97, 95% CI: ). Conclusion: The Gujarati Asian Indians are subjected to premature vascular ageing and henceforth routine screening for vascular age and risk factors prevalence is strongly advocated in this ethnic group. mechanization. 2 In case of CAD, the unique phenotypic profile of Asians differentiate them from other populations which suggest possible involvement of ethnicity based causative factors. 3 Earlier reports have also indicated the presence of CVD and neurological disorder genes in Indians, especially in Guajaratis. 4,5! The Author Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please journals.permissions@oup.com

2 106 K.H. Sharma et al. Prognosis and prediction of coronary heart disease (CHD) and other cardiovascular events are complex processes involving the study of interactions between genetic and environmental factors over an extended period of time. One of the most accepted model for CHD risk prediction was proposed and developed by Framingham investigators in The original study was a communitybased study of 5209 white subjects selected from a suburb west of Boston. In spite of this, the accuracy of Framingham equation in predicting the CHD risk in culturally diverse population is fairly high and uniform due to its systematic validation in various populations. 7,8 This simplified coronary prediction model, uses a multivariate statistical analysis involving blood pressure, cholesterol and low density lipoprotein cholesterol (LDL-C) categories as proposed by the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC-V) and NCEP ATP II for 10 years CHD risk estimation. 6 Vascular age or Heart age is a novel concept derived from Framingham cardiovascular risk tables in This process is accelerated in presence of different cardiovascular risk factors is associated with changes in the mechanical and the structural properties of the vascular wall, which leads to the loss of arterial elasticity. 10 In Framingham vascular age calculations, the CVD risk of an individual is transformed to the age of a person with the same risk but all other risk factors at the normal level. The identification of expressed risk factors in case of silent or asymptomatic CADs by Framingham vascular age multivariate algorithm provides prognostic value for the management of the disease. 11 In spite of great degree of susceptibility of Gujarati Asian Indians to CADs 12 none of the study has addressed the issue of gap between vascular age and actual age in apparently healthy individuals. Due to this lacuna in epidemiological research, this study was planned to screen asymptomatic Gujarati population for progressive vascular aging at a large scale. Materials and Methods Design and data collection This cross-sectional and randomized screening study, conducted by U.N. Mehta Institute of cardiology and research center was approved and clear by institutional ethics committee (UNMICRC/ CARDIO/14/52). Total 2483 individuals of both the genders (1477 males and 1006 females), who were apparently healthy, asymptomatic, disease free and ranging in age from 30 to 74 years were included in the study. The subjects taking any medications and with abnormal stress test were excluded from the investigation. All patients had normal baseline electrocardiography (ECG) and 2D echocardiography. The details of demographic data, ethnicity, family history of CAD and smoking were collected for each individual. Cardiovascular risk factors Subjects were advised to fast at least for 12 h before blood investigations. Total cholesterol (TC), triglycerides (TG), total lipid (TL), lipoproteins low density lipoproteins (LDL), high density lipoprotein (HDL), and very low density lipoprotein (VLDL) and glucose concentrations were measured by International Federation of Clinical Chemistry (IFCC) approved enzymatic methods using commercially available kit on auto analyzer (ARCHITECH PLUS ci4100, Germany). Lipids levels were classified according to the recommendations of National Cholesterol Education Program (NCEP) and Adult Treatment Panel III (ATP III) guidelines. Blood pressure of the population was measured as per the earlier reported guidelines and hypertension was diagnosed if the systolic blood pressure was higher than 140 mmhg or the diastolic blood pressure was above 90 mmhg. 13 Individuals having body mass index (BMI) greater than 30 were considered to be obese as per World Health Organization standards. 14 Abnormal (High) WC was defined using two cutoff points of >90 cm in men and >80 cm in women. 15 The Vascular age was calculated by using Framingham vascular age calculator. Framingham vascular age assessment In Gujarati Asian Indian cohort study, the calculations of vascular age were performed according to definition of D Agostino et al. 9 in the tables from the 2008 FHS. ( risk-functions/cardiovascular-disease/10-year risk. php). We had enrolled the population having age between 30 and 74 years as indicated by Framingham vascular age calculators. The risk factors assessed were age, gender, smoking, TC level, systolic blood pressure and diabetes. The prediction calculation for risk factors were done using continuous functions rather than the point system to add more accuracy. Categorization of the population The study population was categorized in three cohorts based on their age. Cohort I: Vascular age lesser than the chronological age

3 Are Gujarati Asian Indians older for their vascular age? 107 Cohort II: Vascular age equal to the chronological age Cohort III: Vascular age greater than the chronological age Statistical analysis The statistical calculations were performed using SPSS software v 20.0 (Chicago, IL, USA) Quantitative data was expressed as mean SD whereas qualitative data was expressed as percentage. Univariate analysis of the continuous data was performed using student s t-test, whereas chi-square test was used for the categorical data. One-way analysis of variance (ANOVA) was applied to compare the results of three cohorts. The cut off value of P < 0.05 was considered for the statistical significance. Linear regression model was applied to the data to measure the strength of particular risk factors in predicting premature vascular ageing. Results The demographic and clinical presentation of the population are presented in Table 1. The mean age of the overall cohort was 46.8 (10.35) years and mean vascular age was (16.05) years. Table 1 The difference between both the ages ( ) was statistically significant (P < ). The life style induced risk factors such as centripetal obesity (males 56.46%, females 78.28%) hypertension (43.89%) and various dyslipidemias (10 88%) were highly prevalent in Gujarati Asian community. Family history of CAD was found in 34.55% of the population, 13.37% individuals were obese and 10.79% subjects were having habit of smoking. Distribution and comparison trend analysis of various risk factors within all three cohort revealed that most of the individuals (72.45%) were having vascular age greater than their chronological age (Table 2). Only and 5.19% of the population was having vascular age lesser or equal to the actual chronological age, respectively. From the results, it was also prominent that the population affected by advanced vascular age were more male (66.2%) and relatively older (75.4%). Almost all risk factors such as dyslipidemia, diabetes, family history, smoking, hypertension and BMI and WC were significantly higher in advanced vascular age group when compared withequal and lesser vascular age group individuals. The key contributors of vascular age progression were abnormalities of various lipids as follows (TC: 49.3%, TG: 13.4%, HDL in males: 60.4%, HDL in females: 8.4%, LDL: 59.9%, VLDL: Demographic and clinical characteristics of the study population at the time of vascular age calculation a Variables Mean SD/number (%) Chronological age Vascular age * Difference Blood sugar 107 (4.3) Cholesterol 975 (39.26) Triglyceride (TG) 249 (10) High density lipoprotein (HDL) Males 1307 (88) Female 212 (21.1) Low density lipoprotein (LDL) 1014 (40.83) Low density lipoprotein/high density lipoprotein ratio (LDL/HDL) 1155 (46.5) Total cholesterol/high density lipoprotein (TC/HDL) 1323 (53.28) Triglyceride/high density lipoprotein (TG/HDL) 554 (22.31) Very low density lipoprotein (VLDL) 369 (14.86) Total lipids (TL) 617 (24.8) Family history 858 (34.55) Smoking 268 (10.79) Hypertension 1090 (43.89) Body mass index (BMI) (kg/m 2 ) 332 (13.37) Waist circumference (WC) (cm) Male 834 (56.46) Female 786 (78.28) a Values are expressed as mean SD or number and percentage. Values in the parentheses denote percentage. Significantly different (*P < ) when compared with chronological age.

4 108 K.H. Sharma et al. Table 2 Distribution and comparison trends of various risk factors according to vascular age deviations a Variables Cohort I (575) N (%) Cohort II (129) N (%) Cohort III (1779) N (%) Significance P-value Chronological age Vascular age Difference Gender Male 227 (39.5) 72 (55.8) 1178 (66.2) < Female 348 (60.5) 57 (44.2) 601 (33.8) < Age years (47.7) 65 (50.4) 438 (24.6) < > (52.3) 64 (49.4) 1341 (75.4) < Blood sugar 3 (0.5) 0 (0) 104 (5.8) < Cholesterol 76 (13.2) 23 (17.8) 877 (49.3) < Triglyceride (TG) 6 (1.0) 5 (3.9) 239 (13.4) < High density lipoprotein (HDL) Males 169 (29.4) 63 (48.8) 1075 (60.4) < Females 53 (9.2) 10 (7.8) 149 (8.4) Low density lipoprotein (LDL) 69 (12.0) 22 (17.1) 924 (59.9) < Low density lipoprotein/high density lipoprotein (LDL/HDL) 60 (10.4) 25 (19.4) 1071 (60.2) < Total cholesterol/high density lipoprotein (TC/HDL) 79 (13.7) 32 (24.8) 1213 (68.2) < Triglyceride/high density lipoprotein (TG/HDL) 54 (9.4) 16 (12.4) 485 (27.3) < Very low density lipoprotein (VLDL) 17 (3.0) 6 (4.7) 347 (19.5) < Total lipids (TL) 31 (5.4) 5 (3.9) 582 (32.7) < Family history 175 (30.4) 48 (37.2) 635 (35.7) Smoking 11 (1.9) 6 (4.7) 251 (14.1) < Hypertension 44 (7.7) 26 (20.15) 1019 (57.34) < Body mass index (BMI) (kg/m 2 ) 60 (10.4) 13 (10.1) 260 (14.6) Waist circumference (WC) (cm) Males 94 (16.3) 34 (26.4) 706 (39.7) < Females 231 (40.2) 40 (31) 516 (29) < a Values are presented as number, percentage. Cohort I, Individuals having vascular age lesser than their chronological age; Cohort II, Individuals having vascular age equals to their chronological age; Cohort III, Individuals having vascular age greater than their chronological age. 19.5%, TL: 32.7%, LDL/HDL ratio: 60.2%, TC/HDL ratio: 68.2% and TG/HDL ratio: 27.3%), whereas hypertension in 57.34% and increased WC in 39.7% males and in 29% females. Prevalence of diabetes (5.8%) and smoking (14.1%) increases as the gap between vascular age and real age widens, however their contribution in the vascular age advancement was not as strong as the other risk factors. The distribution of various risk factors in advanced vascular age group was further categorized according to gender and age and is indicated in Tables 3 and 4, respectively. Table 3 shows that chronological age of male and females suffering from premature vascular ageing was almost similar, however mean vascular age of the females was significantly (P = ) higher ( ) than males ( ). Moreover the older males (72.9%) and females (80.2%) were having higher vascular age when compared with young ones (27.07% males, 19.8% females). Distribution of various risk factors such as elevated TG (15.8 vs. 8.8%), LDL/HDL ratio (66.2 vs. 48.4%), TC/HDL ratio (75.6 vs. 53.7%), TG/HDL ratio (32.3 vs. 17.3%), VLDL (22.6 vs. 13.5%), TL (33.8 vs. 30.6%), low HDL (91.3 vs. 24.8%), family history of CAD (37 vs. 33.1%) and smoking (17.4 vs. 7.7%) was higher in males when compared with females. However, hypertension, obesity and increased WC were more prevalent in females (61.4, 18.8 and 85.9%) than in males (55.2, 12.5 and 59.9%), respectively. Table 4 shows that vascular age deviation increases with natural aging and were associated with elevation in TC (52.2%), high LDL (54.9%), hypertension (60.4%), and high WC (males: 40.5%; females: 31.2%). We have also observed that the gap between vascular and chronological age was greater in older individuals ( ) when compared

5 Are Gujarati Asian Indians older for their vascular age? 109 Table 3 Genderwise distribution of risk factors in population having advanced vascular age a Variables for positive difference (1779) Males (1178) N (%) Females (601) N (%) Significance P-value Chronological age Vascular age Difference Age years (27.07) 119 (19.8) > (72.9) 482 (80.2) Blood sugar 75 (6.4) 29 (4.8) Cholesterol 562 (47.7) 315 (52.4) Triglyceride (TG) 186 (15.8) 53 (8.8) High density lipoprotein (HDL) 1075 (91.3) 149 (24.8) < Low density lipoprotein (LDL) 605 (51.4) 319 (53.1) Low density lipoprotein/high density lipoprotein (LDL/HDL) 780 (66.2) 291 (48.4) < Total cholesterol/high density lipoprotein (TC/HDL) 890 (75.6) 323 (53.7) < Triglyceride/high density lipoprotein (TG/HDL) 381 (32.3) 104 (17.3) < Very low density lipoprotein (VLDL) 266 (22.6) 81 (13.5) < Total lipids (TL) 398 (33.8) 184 (30.6) Family history 436 (37) 199 (33.1) Smoking 205 (17.4) 46 (7.7) < Hypertension 650 (55.2) 369 (61.4) Body mass index (BMI) (kg/m 2 ) 147 (12.5) 113 (18.8) Waist circumference (WC) (cm) 706 (59.9) 516 (85.9) < a Values are presented as number, percentage. with the young ( ). Combined results of Tables 3 and 4 revealed that ageing of vessels targets males at younger age (72.8%) and this could be due to abnormality of HDL, which was higher (69.4%) in young males when compared with their older counterparts (57.5%). The strength of association of individual risk factor in the vascular ageing was estimated with the by logistic regression analysis (Table 5). It showed that vascular age progression was highly associated with hypertension 19.9 (95% CI ), followed by smoking (95% CI ) and elevated blood sugar (95% CI ). In spite of the fact that their weak association with increased vascular age in the study population, the results of odds ratio point out that individuals with diabetes or smoking had relatively higher chances of developing vascular diseases when compared with others. Discussion To the best of our knowledge, this is the first ever large cross sectional study designed to assess individuals for increased vascular age in Gujarati Asian Indian cohort. This work also provides some of the most relevant findings regarding the factors involved in advanced vascular age in apparently healthy and asymptomatic Gujarati Asian Indians. Surprisingly, we found that only 23.15% of the population was having vascular age lesser than their chronological age, where as 72.45% of the population was suffering from premature vascular ageing making them susceptible for occurrence of CVD. D Agostino et al. had developed a simple algorithm involving classical risk factors of CHD such age, lipids, systolic blood pressure, treatment for hypertension, smoking and diabetes to quantify a multivariable risk of CHD in the form of vascular age. 9 This study observation of Gujarati Asian Indians cohort lead us to identify dyslipidemia (60.4%), hypertension (57.34%) and centripetal obesity (male 39.7%, females 29%) as key contributors of increased vascular age. On the contrary, in spite of their proven role in CHD in other ethnic cohort diabetes (5.8%) and smoking (14.1%) were found to be weakly associated with vascular age in Gujarati Asian Indians. Disturbance in lipid metabolism often leads to the manifestation of various types of dyslipidemias triggering inflammatory processes causing atherosclerotic disorders. 16 One of the first land mark finding of Framingham study was the establishment of relationship between TC and CHD risk. Nowadays, the cholesterol centric approach to CVD is an obsolete concept as the high levels of LDL, elevated TG, TL,

6 110 K.H. Sharma et al. Table 4 Agewise distribution of risk factors in population having advanced vascular age a Variables Age 40 years (438) N (%) Age >40 years (1341) N (%) Significance P value Chronological age Vascular age Difference Gender Males 319 (72.8) 859 (64.1) Females 119 (27.2) 482 (35.9) Blood sugar 11 (2.5) 93 (6.9) Cholesterol 177 (40.4) 700 (52.2) < Triglyceride (TG) 63 (14.4) 176 (13.1) High density lipoprotein (HDL) Males 304 (69.4) 771 (57.5) < Females 42 (9.6) 107 (8.0) Low density lipoprotein (LDL) 188 (42.9) 736 (54.9) < Low density lipoprotein/high density lipoprotein (LDL/HDL) 269 (61.4) 802 (59.8) Total cholesterol/high density lipoprotein (TC/HDL) 308 (70.3) 905 (67.5) Triglyceride/high density lipoprotein (TG/HDL) 120 (27.4) 365 (27.2) Very low density lipoprotein (VLDL) 94 (21.5) 253 (18.9) Total lipids (TL) 136 (31.1) 446 (33.3) Family history 188 (42.9) 447 (33.3) Smoking 74 (16.9) 177 (13.2) Hypertension 209 (47.7) 810 (60.4) < Body mass index (BMI) (kg/m 2 ) 49 (11.2) 211 (15.7) Waist circumference (WC) (cm) Males 163 (37.2) 543 (40.5) Females 97 (22.1) 419 (31.2) a Values are presented as number, percentage. Table 5 Multivariate logistic regression analysis for premature vascular ageing by gender, age, blood sugar, lipid profile, family history, smoking, hypertension, and body mass index and waist circumference a Variables B Sig. Exp(B) 95% CI for EXP(B) Lower Upper Gender Age Blood sugar Cholesterol Triglyceride (TG) High density lipoprotein (HDL) Low density lipoprotein cholesterol (LDL) Low density lipoprotein cholesterol/high density lipoprotein (LDL/HDL) Total cholesterol/high density lipoprotein (TC/HDL) Triglyceride/high density lipoprotein (TG/HDL) Very low density lipoprotein (VLDL) Total Lipids (TL) Family history Smoking Hypertension Body mass index (BMI) (kg/m 2 ) Waist circumference (WC) (cm) a Linear regression model analysis. B, Beta coefficient; Exp (B), exponentiation of the coefficients/odds ratios of the predictors, CI, confidence interval.

7 Are Gujarati Asian Indians older for their vascular age? 111 VLDLs and low levels of HDL are also known to contribute in vascular age progression which was later updated by Framingham investigators also. 17 In the same line, we have also observed key association between various dyslipidemias (8.4% to 68.2%) and growing vascular age in Gujarati Asian Indians. Outcomes of present investigation states that the dyslipidemia prevalence are subjected to gender variance as majority of the responders of lipid abnormalities were male which is in agreement with previous reports. 18 We have also observed that females had better cardiovascular risk factor profile especially in case of lipids when compared with males, where abnormalities of HDL were alarmingly high (91%) in Gujarati Asian Indian males. The fairer lipid profile in females could be partly explained by the antioxidant, DNA protective and vascular flexibility enhancing properties of estrogen which helps in delaying onset of CVD events in females by years when compared with men. 19,20,21 HDL being anti-atherogenic lipoprotein provides cardio-protection through various mechanisms such as reverse transport of cholesterol, preventing endothelial dysfunction and antioxidative properties. Numerous clinical and epidemiological studies have shown inverse correlation between HDL level and coronary events. 22 HDL abnormality was found to target the population at relatively early age in both the gender indicating early need for diet and life style modification. Hypertension has long been recognized as an attributable risk factor of CVD and several epidemiological studies such as INTERHEART and Framingham had recommended its use as a powerful prognosticator of future CVD events. 17,23 Likewise this study also establishes hypertension as one of the strongest predictor of advanced vascular age showing higher frequencies in older individuals (60.4%) when compared with young (47.7%), which is in accordance with earlier reported studies. 24 The overall population affected by high blood pressure reported in our study (57.34%) was relatively higher than other documented studies (16.9%). 25 However in contrast to others, 24 we have found that Gujarati females (61.4%) are more likely to be hypertensive than males (55.2%). This remarkable loss of the estrogen protective effect in Gujarati females could be partially explained by less effective baroreflex buffering of blood pressure in women than men and presence of associated comorbidities. 26 Centripetal obesity, as defined by WC is one of prime indicator of disturbed lipid metabolism and is an independent risk factor of atherosclerotic. 27 Although not incorporated in Framingham equation, the IDEA study presented that visceral obesity is linearly related to the incidence of CAD regardless of BMI. 28 Similar to other reports from India, in our study population also the centripetal obesity was contributing risk factor for progressive vascular age, which was more prevalent in males (39.7%) than in females (29%). 29 We have observed that the increase in vascular age was greater in older individuals as 75.4% of the population affected with advanced vascular age were having chronological age above 40 years. Natural ageing allied changes in lipids were observed in TC and LDL whereas levels of TG, VLDL, TL were unaffected by the age of an individual. Ageing induces dysfunctional arteries by increasing arterial stiffness, oxidative stress and reducing arterial compliance and promotes CVD risk factors. 10 Our results clearly states that the gap between vascular age and chronological age gets widened as people grow older due to greater expression of framingham equation risk factors. Conclusion 1. Gujarati Asian Indians are older for their vascular age by 6.54 (9.5) years when compared with their chronological age. 2. The risk factors contributing to the advanced vascular age for Gujarati Asian Indians are dyslipidemia, hypertension and centripetal obesity, apart from chronological ageing and male gender. 3. Diabetes and smoking showed lesser influence in the study group and this could be partly explained by the fact that distribution of CVD risk factors are highly prone to ethnic and genetic variation making some population more susceptible to certain diseases. 4. These finding may explain earlier occurrence of CVD in Asian Indians approximately by a decade than Caucasian population. In the light of our findings, routine screening for advanced vascular age and potential at risk population in asymptomatic patients is strongly advocated. Acknowledgements The authors are grateful to the Director, Dr. R. K. Patel, Yogini Kandre, Pratik Shah and Himanshu Acharya for their valuable support in the completion of this project. Funding This work was supported by U.N. Mehta Institute of Cardiology and Research Centre, Gujarat, India. Conflict of interest: None declared.

8 112 K.H. Sharma et al. References 1. Ebrahim S, Smith GD. Exporting failure? Coronary heart disease and stroke in developing countries. Int J Epidemiol 2001; 30: Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998; 97: North KE, Howard BV, Welty TK, Best LG, Lee ET, Yeh J, et al. Genetic and environmental contributions to cardiovascular disease risk in American Indians The Strong Heart Family Study. Am J Epidemiol 2003; 157: De Maat MP, Green F, de Knijff P, Jespersen J, Kluft C. Factor VII polymorphisms in populations with different risks of cardiovascular disease. Arterioscler Thromb Vasc Biol 1997; 17: Patel H, Mistri M, Ankleshwaria C, Sheth F, Sheth J. Frequency analysis of Spinocerebellar ataxia types 1, 2, 3 & 6 in patients with ataxia from Gujarat. Mol Cytogenet 2014; 7(Suppl. 1):P Wilson PW, D Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: D Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001; 286: Quirke T, Gill P, Mant J, Allan T. The applicability of the Framingham coronary heart disease prediction function to black and minority ethnic groups in the UK. Heart 2003; 89: D Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care the Framingham Heart Study. Circulation 2008; 117: Lee S-J, Park S-H. Arterial ageing. Korean Circ J 2013; 43: Reinoso-Barbero L, Capape-Aguilar A, Diaz-Garrido R, Santiago Dorrego C, Gomez-Gallego F, Bandres Moya F. Cardiovascular risk prediction and its relationship with metabolic syndrome and emerging serum makers in occupational health surveillance. Arch Prev Riesgos Labor 2014; 17: Hoogeveen RC, Gambhir JK, Gambhir DS, Kimball KT, Ghazzaly K, Gaubatz JW, et al. Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. J Lipid Res 2001; 42: Indian Consensus Group. Indian consensus for prevention of coronary artery disease: A joint scientific statement of Indian society of hypertension and International College of Nutrition. J Nutr Environ Med 1996; 6: World Health Organization (2005). World health report Reducing risks, promoting healthy life. Geneva. (9 June 2014, date last accessed). 15. Misra A, Vikram N, Gupta R, Pandey R, Wasir J, Gupta V. Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity. Int J Obesity 2006; 30: Faxon DP, Fuster V, Libby P, Beckman JA, Hiatt WR, Thompson RW, et al. Atherosclerotic Vascular Disease Conference Writing Group III: Pathophysiology. Circulation 2004; 109: O Donnell CJ, Elosua R. Cardiovascular risk factors. Insights from Framingham Heart Study. Revista Espanola de Cardiologia (English Edition) 2008; 61: Estari M, Reddy A, Bikshapathi T, Satyanarayana J, Venkanna L, Reddy M. The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India. Biol Med 2009; 1: Subbiah MR. Mechanisms of cardioprotection by estrogens. Exp Biol Med 1998; 217: Wenger NK. Coronary Heart Disease in Women: Evolving Knowledge is Dramatically Changing Clinical Care. Women and Heart Disease. London, Martin Dunitz, Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year followup of the Framingham population. Am Heart J 1986; 111: Rye K-A, Bursill CA, Lambert G, Tabet F, Barter PJ. The metabolism and anti-atherogenic properties of HDL. J Lipid Res 2009; 50(Suppl.):S195 S Ajay VS, Prabhakaran D. Coronary heart disease in Indians: Implications of the INTERHEART study. Indian J Med Res 2010; 132: Momin MH, Desai VK, Kavishwar AB. Study of socio-demographic factors affecting prevalence of hypertension among bank employees of Surat City. Indian J Public Health 2012; 56: Tiwari RR. Hypertension and epidemiological factors among tribal labour population in Gujarat. Indian J Public Health 2008; 52: Christou DD, Jones PP, Jordan J, Diedrich A, Robertson D, Seals DR. Women have lower tonic autonomic support of arterial blood pressure and less effective baroreflex buffering than men. Circulation 2005; 111: Bose S, Krishnamoorthy P, Varanasi A, Nair J, Schutta M, Braunstein S, et al. Measurement of waist circumference predicts coronary atherosclerosis beyond plasma adipokines. Obesity 2013; 21:E118 E Balkau B, Deanfield JE, Després J-P, Bassand J-P, Fox KA, Smith SC, et al. International Day for the Evaluation of Abdominal Obesity (IDEA) A Study of Waist Circumference, Cardiovascular Disease, and Diabetes Mellitus in Primary Care Patients in 63 Countries. Circulation 2007; 116: Pais P, Pogue J, Gerstein H, Zachariah E, Savitha D, Jayprakash S, et al. Risk factors for acute myocardial infarction in Indians: a case-control study. The Lancet 1996; 348:

CARDIOVASCULAR DISEASE RISK FACTOR ESTIMATION IN GUJARATI ASIAN INDIAN POPULATION USING FRAMINGHAM RISK EQUATION

CARDIOVASCULAR DISEASE RISK FACTOR ESTIMATION IN GUJARATI ASIAN INDIAN POPULATION USING FRAMINGHAM RISK EQUATION ORIGINAL ARTICLE CARDIOVASCULAR DISEASE RISK FACTOR ESTIMATION IN GUJARATI ASIAN INDIAN POPULATION USING FRAMINGHAM RISK EQUATION Sibasis Sahoo 1, Komal Shah 2,Anand Shukla 3, Jayesh Prajapati 3, Pratik

More information

The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India

The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India eissn: 09748369, www.biolmedonline.com The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India M Estari, AS Reddy, T Bikshapathi,

More information

Association of Major Modifiable Risk Factors Among Patients with Coronary Artery Disease - A Retrospective Analysis

Association of Major Modifiable Risk Factors Among Patients with Coronary Artery Disease - A Retrospective Analysis Original Article Association of Major Modifiable Risk Factors Among Patients with Coronary Artery Disease - A Retrospective Analysis V Achari, AK Thakur Abstract Background : The relative importance of

More information

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original

More information

Atherosclerotic Disease Risk Score

Atherosclerotic Disease Risk Score Atherosclerotic Disease Risk Score Kavita Sharma, MD, FACC Diplomate, American Board of Clinical Lipidology Director of Prevention, Cardiac Rehabilitation and the Lipid Management Clinics September 16,

More information

Total risk management of Cardiovascular diseases Nobuhiro Yamada

Total risk management of Cardiovascular diseases Nobuhiro Yamada Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible

More information

Guidelines on cardiovascular risk assessment and management

Guidelines on cardiovascular risk assessment and management European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine

More information

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES Int. J. LifeSc. Bt & Pharm. Res. 2013 Varikasuvu Seshadri Reddy et al., 2013 Review Article ISSN 2250-3137 www.ijlbpr.com Vol. 2, No. 1, January 2013 2013 IJLBPR. All Rights Reserved THE EFFECT OF VITAMIN-C

More information

EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT Submitted to UNIVERSITY GRANTS COMMISSION

EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT Submitted to UNIVERSITY GRANTS COMMISSION 1 A STUDY ON THE EFFECT OF DIET & LIFE STYLE ON THE INCIDENCE OF CORONARY ARTERY DISEASE IN MODERATELY DRINKING EX MILITARY MEN IN PATHANAMTHITTA DISTRICT. EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT

More information

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein

More information

The Metabolic Syndrome: Is It A Valid Concept? YES

The Metabolic Syndrome: Is It A Valid Concept? YES The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines

More information

Identification of subjects at high risk for cardiovascular disease

Identification of subjects at high risk for cardiovascular disease Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April 14 2011 Identification of subjects at high risk for cardiovascular disease Lars Rydén Karolinska Institutet

More information

It is currently estimated that diabetes prevalence by

It is currently estimated that diabetes prevalence by clinical Study The Prevalence and Pattern of Dyslipidemia among Type 2 Diabetic Patients at Rural Based Hospital in Gujarat, India Hetal Pandya*, JD Lakhani**, J Dadhania, A Trivedi Abstract Only proper

More information

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Know Your Number Aggregate Report Single Analysis Compared to National Averages Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics

More information

DYSLIPIDAEMIC PATTERN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. Eid Mohamed, Mafauzy Mohamed*, Faridah Abdul Rashid

DYSLIPIDAEMIC PATTERN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. Eid Mohamed, Mafauzy Mohamed*, Faridah Abdul Rashid Malaysian Journal of Medical Sciences, Vol. 11, No. 1, January 2004 (44-51) ORIGINAL ARTICLE DYSLIPIDAEMIC PATTERN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS Eid Mohamed, Mafauzy Mohamed*, Faridah Abdul

More information

Andrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University

Andrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University CARDIOVASCULAR RISK FACTORS ORIGINAL ARTICLE Do We Correctly Assess the Risk of Cardiovascular Disease? Characteristics of Risk Factors for Cardiovascular Disease Depending on the Sex and Age of Patients

More information

DECLARATION OF CONFLICT OF INTEREST. None

DECLARATION OF CONFLICT OF INTEREST. None DECLARATION OF CONFLICT OF INTEREST None BURDEN OF CORONARY ARTERY DISEASE IN DIABETES IN INDIA Amal Kumar Banerjee MD, DM,FACC,FESC,FACP,FAPSC,FICC President Association of Physicians of India SAARC Cardiac

More information

SUPPLEMENTAL MATERIAL. Materials and Methods. Study design

SUPPLEMENTAL MATERIAL. Materials and Methods. Study design SUPPLEMENTAL MATERIAL Materials and Methods Study design The ELSA-Brasil design and concepts have been detailed elsewhere 1. The ELSA-Brasil is a cohort study of active or retired 15,105 civil servants,

More information

Prediction of Cardiovascular Disease in suburban population of 3 municipalities in Nepal

Prediction of Cardiovascular Disease in suburban population of 3 municipalities in Nepal Prediction of Cardiovascular Disease in suburban population of 3 municipalities in Nepal Koju R, Gurung R, Pant P, Humagain S, Yogol CM, Koju A, Manandhar K, Karmacharya B, Bedi TRS Address for Correspondence:

More information

Metabolic Syndrome and Workplace Outcome

Metabolic Syndrome and Workplace Outcome Metabolic Syndrome and Workplace Outcome Maine Worksite Wellness Initiative June 15, 2010 Alyssa B. Schultz Dee W. Edington Current Definition* of Metabolic Syndrome At least 3 of the following: Waist

More information

Epidemiologic Measure of Association

Epidemiologic Measure of Association Measures of Disease Occurrence: Epidemiologic Measure of Association Basic Concepts Confidence Interval for population characteristic: Disease Exposure Present Absent Total Yes A B N 1 = A+B No C D N 2

More information

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors

Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti

More information

Diabetes, Diet and SMI: How can we make a difference?

Diabetes, Diet and SMI: How can we make a difference? Diabetes, Diet and SMI: How can we make a difference? Dr. Adrian Heald Consultant in Endocrinology and Diabetes Leighton Hospital, Crewe and Macclesfield Research Fellow, Manchester University Relative

More information

CVD Prevention, Who to Consider

CVD Prevention, Who to Consider Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..

More information

Diabetes Care 31: , 2008

Diabetes Care 31: , 2008 Cardiovascular and Metabolic Risk O R I G I N A L A R T I C L E Global Coronary Heart Disease Risk Assessment of Individuals With the Metabolic Syndrome in the U.S. KHIET C. HOANG, MD HELI GHANDEHARI VICTOR

More information

Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution

Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution CLINICAL Viewpoint Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients Copyright Not for Sale or Commercial Distribution By Ruth McPherson, MD, PhD, FRCPC Unauthorised

More information

Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study

Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study Hidenori Arai 1, Yoshihiro Kokubo 2, Makoto Watanabe 2, Tatsuya Sawamura 3, Tomonori

More information

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes Katherine Baldock Catherine Chittleborough Patrick Phillips Anne Taylor August 2007 Acknowledgements This project was made

More information

Metabolic Syndrome: Why Should We Look For It?

Metabolic Syndrome: Why Should We Look For It? 021-CardioCase 29/05/06 15:04 Page 21 Metabolic Syndrome: Why Should We Look For It? Dafna Rippel, MD, MHA and Andrew Ignaszewski, MD, FRCPC CardioCase presentation Andy s fatigue Andy, 47, comes to you

More information

RESEARCH ARTICLE. Abbasi et al., IJAVMS, Vol. 6, Issue 5, 2012: DOI: /ijavms.24458

RESEARCH ARTICLE. Abbasi et al., IJAVMS, Vol. 6, Issue 5, 2012: DOI: /ijavms.24458 RESEARCH ARTICLE Abbasi et al., IJAVMS, Vol. 6, Issue 5, : 385-39 DOI:.5455/ijavms.4458 Prevalence and Awareness of Cardiovascular Disease Risk Factors in the Government Servants of Muzaffarabad, the Capital

More information

1. Which one of the following patients does not need to be screened for hyperlipidemia:

1. Which one of the following patients does not need to be screened for hyperlipidemia: Questions: 1. Which one of the following patients does not need to be screened for hyperlipidemia: a) Diabetes mellitus b) Hypertension c) Family history of premature coronary disease (first degree relatives:

More information

Eyes on Korean Data: Lipid Management in Korean DM Patients

Eyes on Korean Data: Lipid Management in Korean DM Patients Eyes on Korean Data: Lipid Management in Korean DM Patients ICDM Luncheon Symposium Sung Rae Kim MD PhD Division of Endocrinology and Metabolism The Catholic University of Korea Causes of Death in People

More information

Gender-Based and Age-Related Peculiarities of Lipid Metabolism in Chronic Heart Failure Secondary to Overweight and Obesity

Gender-Based and Age-Related Peculiarities of Lipid Metabolism in Chronic Heart Failure Secondary to Overweight and Obesity 71 P.P.Bidzilya Gender-Based and Age-Related Peculiarities of Lipid Metabolism in Chronic Heart Failure Secondary to Overweight and Obesity Zaporizhzhya State Medical University, Zaporizhzhya, Ukraine

More information

Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies

Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies A Consensus Statement from the European Atherosclerosis Society

More information

The Whitehall II study originally comprised 10,308 (3413 women) individuals who, at

The Whitehall II study originally comprised 10,308 (3413 women) individuals who, at Supplementary notes on Methods The study originally comprised 10,308 (3413 women) individuals who, at recruitment in 1985/8, were London-based government employees (civil servants) aged 35 to 55 years.

More information

Study of cardiovascular risk factor profile among first-degree relatives of patients with premature coronary artery disease at Kota, Rajasthan, India

Study of cardiovascular risk factor profile among first-degree relatives of patients with premature coronary artery disease at Kota, Rajasthan, India International Journal of Community Medicine and Public Health Mittal D et al. Int J Community Med Public Health. 2016 Jul;3(7):1894-1899 http://www.ijcmph.com pissn 2394-6032 eissn 2394-6040 Research Article

More information

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple

More information

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular

More information

Socioeconomic status risk factors for cardiovascular diseases by sex in Korean adults

Socioeconomic status risk factors for cardiovascular diseases by sex in Korean adults , pp.44-49 http://dx.doi.org/10.14257/astl.2013 Socioeconomic status risk factors for cardiovascular diseases by sex in Korean adults Eun Sun So a, Myung Hee Lee 1 * a Assistant professor, College of Nursing,

More information

The Framingham Coronary Heart Disease Risk Score

The Framingham Coronary Heart Disease Risk Score Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

Frequency of Dyslipidemia and IHD in IGT Patients

Frequency of Dyslipidemia and IHD in IGT Patients Frequency of Dyslipidemia and IHD in IGT Patients *Islam MS, 1 Hossain MZ, 2 Talukder SK, 3 Elahi MM, 4 Mondal RN 5 Impaired glucose tolerance (IGT) is often associated with macrovascular complications.

More information

the U.S. population, have some form of cardiovascular disease. Each year, approximately 6 million hospitalizations

the U.S. population, have some form of cardiovascular disease. Each year, approximately 6 million hospitalizations Cardioprotection: What is it? Who needs it? William B. Kannel, MD, MPH From the Department of Preventive Medicine and Epidemiology, Evans Department of Clinical Research, Boston University School of Medicine,

More information

Global Coronary Heart Disease Risk Assessment of U.S. Persons With the Metabolic. Syndrome. and Nathan D. Wong, PhD, MPH

Global Coronary Heart Disease Risk Assessment of U.S. Persons With the Metabolic. Syndrome. and Nathan D. Wong, PhD, MPH Diabetes Care Publish Ahead of Print, published online April 1, 2008 Global Coronary Heart Disease Risk Assessment of U.S. Persons With the Metabolic Syndrome Khiet C. Hoang MD, Heli Ghandehari, BS, Victor

More information

Clinical Recommendations: Patients with Periodontitis

Clinical Recommendations: Patients with Periodontitis The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease. Friedewald VE, Kornman KS, Beck JD, et al. J Periodontol 2009;

More information

The Framingham Risk Score (FRS) is widely recommended

The Framingham Risk Score (FRS) is widely recommended C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score Implications for Future Risk Assessment: Results From a Large Cohort Study in Southern Germany Wolfgang Koenig, MD; Hannelore

More information

Risk Factors for Heart Disease

Risk Factors for Heart Disease Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress

More information

A study of waist hip ratio in identifying cardiovascular risk factors at Government Dharmapuri College Hospital

A study of waist hip ratio in identifying cardiovascular risk factors at Government Dharmapuri College Hospital Original Research Article A study of waist hip ratio in identifying cardiovascular risk factors at Government Dharmapuri College Hospital M. Arivumani * Assistant Professor of General Medicine, Government

More information

JMSCR Volume 03 Issue 04 Page April 2015

JMSCR Volume 03 Issue 04 Page April 2015 www.jmscr.igmpublication.org Impact Factor 3.79 ISSN (e)-2347-176x Study of Metabolic Syndrome and Thyroid Dysfunction Authors Dr. Nalini R Humaney, Dr. Saurabh Ashok Lande, Dr. Ramesh P Mundle N.K.P.Salve

More information

Unraveling the concealed and calculated cardiovascular risks in diabetes

Unraveling the concealed and calculated cardiovascular risks in diabetes 15 P B Fernando Memorial Oration 2015 Unraveling the concealed and calculated cardiovascular risks in diabetes Weerarathna T P 1 Journal of the Ceylon College of Physicians, 2016, 47, 15-19 Abstract Cardiovascular

More information

How would you manage Ms. Gold

How would you manage Ms. Gold How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56

More information

Impact of Chronicity on Lipid Profile of Type 2 Diabetics

Impact of Chronicity on Lipid Profile of Type 2 Diabetics Impact of Chronicity on Lipid Profile of Type 2 Diabetics Singh 1, Gurdeep & Kumar 2, Ashok 1 Ph.D. Research Scholar, Department of Sports Science, Punjabi University Patiala, India, Email: drgurdeep_sahni@yahoo.co.in

More information

Metabolic Syndrome.

Metabolic Syndrome. www.bmiweightloss.com.au What is the metabolic syndrome? The was first described in 1988 by Gerald Reavson It was originally described as the clustering of four conditions These conditions when present

More information

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary 2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Becky McKibben, MPH; Seth

More information

Journal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.

Journal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32. Journal of the American College of Cardiology Vol. 48, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.03.043

More information

Established Risk Factors for Coronary Heart Disease (CHD)

Established Risk Factors for Coronary Heart Disease (CHD) Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland

More information

On May 2001, the Third Adult

On May 2001, the Third Adult THE RISK OF DIABETES: CAN WE IMPACT CHD THROUGH THE ATP III CHOLESTEROL GUIDELINES? * Based on a presentation given by Steven M. Haffner, MD, MPH ABSTRACT Diabetes has been recognized among diabetologists

More information

Clinical Study of Lipid Profile Pattern in Acute Coronary Syndromes

Clinical Study of Lipid Profile Pattern in Acute Coronary Syndromes Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2017/359 Clinical Study of Lipid Profile Pattern in Acute Coronary Syndromes V Suresh Kumar, Madavaram Sreelatha Assistant

More information

Impact of metabolic syndrome on hospital in acute myocardial infarction patients

Impact of metabolic syndrome on hospital in acute myocardial infarction patients Original Article Impact of metabolic syndrome on hospital in acute myocardial infarction patients Pravin Rohidasrao Bhagat 1*, Shubhangi Virbhadra Swami 2 outcomes { 1 Assistant Professor, Department of

More information

Why Do We Treat Obesity? Epidemiology

Why Do We Treat Obesity? Epidemiology Why Do We Treat Obesity? Epidemiology Epidemiology of Obesity U.S. Epidemic 2 More than Two Thirds of US Adults Are Overweight or Obese 87.5 NHANES Data US Adults Age 2 Years (Crude Estimate) Population

More information

Hae Sun Suh, B.Pharm., Ph.D. Jason N. Doctor, Ph.D.

Hae Sun Suh, B.Pharm., Ph.D. Jason N. Doctor, Ph.D. Podium Presentation, May 18, 2009 Comparison of Cardiovascular Event Rates in Subjects with Type II Diabetes Mellitus who Augmented from Statin Monotherapy to Statin Plus Fibrate Combination Therapy with

More information

Risk factor analysis and trends of dyslipidemia in Type 2 diabetes mellitus subjects of an industrial population.

Risk factor analysis and trends of dyslipidemia in Type 2 diabetes mellitus subjects of an industrial population. Biomedical Research 2010; 21 (4): 371-375 Risk factor analysis and trends of dyslipidemia in Type 2 diabetes mellitus subjects of an industrial population. Shonima Venugopal and Uma M Iyer Department of

More information

Study of fixed dose combination for the management of cardiovascular diseases

Study of fixed dose combination for the management of cardiovascular diseases World Journal of Pharmaceutical Sciences ISSN (Print): 2321-331; ISSN (Online): 2321-386 Available online at: http://www.wjpsonline.org/ Original Article Study of fixed dose combination for the management

More information

A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus

A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus Original Research Article A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus Deepa Kalikavil Puthenveedu 1, Sundaraj

More information

. Non HDL-c : Downloaded from ijdld.tums.ac.ir at 18:05 IRDT on Friday March 22nd Non HDL LDL. . LDL Non HDL-c

. Non HDL-c : Downloaded from ijdld.tums.ac.ir at 18:05 IRDT on Friday March 22nd Non HDL LDL. . LDL Non HDL-c 208-23 (2 ) 0 389 -. Non HDL * Downloaded from ijdld.tums.ac.ir at 8:05 IRDT on Friday March 22nd 209 Non HDL : LDL.. 5 3277 :.. odds ratio Chi-Square %3/9 Non HDL-C %2 LDL-C. %3 : Non-HDL-C LDL-C. (CI

More information

Working together Revista de cercetare [i interven]ie social\

Working together   Revista de cercetare [i interven]ie social\ Working together www.rcis.ro Revista de cercetare [i interven]ie social\ ISSN: 1583-3410 (print), ISSN: 1584-5397 (electronic) Selected by coverage in Social Sciences Citation Index, ISI databases SEX

More information

year resident, Department of Medicine, B. J. Medical college, Ahmedabad.

year resident, Department of Medicine, B. J. Medical college, Ahmedabad. Clinical Study of Type 2 Diabetes Mellitus Patients with or without Cerebrovascular Feature and Its Correlation with Other Comorbidity / Diabetic Complication Vivek Sidhapura 1*, Bipin Amin 2, Amit Potulwar

More information

Low HDL-levels: leave it or treat it?

Low HDL-levels: leave it or treat it? Cardiology Update 2011 Davos, 14 02 2011 Low HDL-levels: leave it or treat it? Experts: J.P. Kastelein, Amsterdam and U. Landmesser, Zurich Cases: C. Besler, Zurich and I. Sudano, Zurich Mr H.B., 1960

More information

Life Science Journal 2018;15(12)

Life Science Journal 2018;15(12) Multicenter observational study of risk factors profile in a sample of Egyptian Patients with Acute Coronary Syndrome (part of Egyptian Cardiovascular Risk Factors Project) Prof. Dr. Ahmed Ashraf Reda,

More information

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This

More information

Echocardiography analysis in renal transplant recipients

Echocardiography analysis in renal transplant recipients Original Research Article Echocardiography analysis in renal transplant recipients S.A.K. Noor Mohamed 1*, Edwin Fernando 2, 1 Assistant Professor, 2 Professor Department of Nephrology, Govt. Stanley Medical

More information

International Journal of Pharma and Bio Sciences

International Journal of Pharma and Bio Sciences Research Article Biochemistry International Journal of Pharma and Bio Sciences ISSN 0975-6299 CORRELATION BETWEEN SERUM URIC ACID LEVELS AND NON HDL CHOLESTEROL IN TYPE II DIABETES MELLITUS AN OBSERVATIONAL

More information

Metabolic Syndrome. Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah

Metabolic Syndrome. Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah Metabolic Syndrome Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah Objectives Be able to outline the pathophysiology of the metabolic syndrome Be able to list diagnostic criteria for

More information

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients 2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type

More information

The Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

The Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk Update 2013 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine Denver Health

More information

Prevalence of Cardiac Risk Factors among People Attending an Exhibition

Prevalence of Cardiac Risk Factors among People Attending an Exhibition IOSR Journal of Nursing and Health Science (IOSR-JNHS) e-issn: 2320 1959.p- ISSN: 2320 1940 Volume 3, Issue 6 Ver. IV (Nov.-Dec. 2014), PP 4-51 Prevalence of Cardiac Risk Factors among People Attending

More information

HDL-C. J Jpn Coll Angiol, 2008, 48: NIPPON DATA80, MEGA study, JELIS, dyslipidemia, risk assessment chart

HDL-C. J Jpn Coll Angiol, 2008, 48: NIPPON DATA80, MEGA study, JELIS, dyslipidemia, risk assessment chart Online publication March 25, 2009 48 6 2007 2007 HDL-C LDL-C HDL-C J Jpn Coll Angiol, 2008, 48: 463 470 NIPPON DATA80, MEGA study, JELIS, dyslipidemia, risk assessment chart 1987 NIPPON DATA80 Iso 10 MRFIT

More information

Lipoprotein Particle Profile

Lipoprotein Particle Profile Lipoprotein Particle Profile 50% of people at risk for HEART DISEASE are not identified by routine testing. Why is LPP Testing The Most Comprehensive Risk Assessment? u Provides much more accurate cardiovascular

More information

A Study to Show Postprandial Hypertriglyceridemia as a Risk Factor for Macrovascular Complications in Type 2 Diabetis Mellitus

A Study to Show Postprandial Hypertriglyceridemia as a Risk Factor for Macrovascular Complications in Type 2 Diabetis Mellitus Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2018/21 A Study to Show Postprandial Hypertriglyceridemia as a Risk Factor for Macrovascular Complications in Bingi Srinivas

More information

GUIDELINES FOR DYSLIPIDEMIA MANAGEMENT AND EDUCATION THROUGH NOVA SCOTIA DIABETES CENTRES

GUIDELINES FOR DYSLIPIDEMIA MANAGEMENT AND EDUCATION THROUGH NOVA SCOTIA DIABETES CENTRES GUIDELINES FOR DYSLIPIDEMIA MANAGEMENT AND EDUCATION THROUGH NOVA SCOTIA DIABETES CENTRES Prepared by DCPNS Action Committee Dr. Lynne Harrigan Brenda Cook Peggy Dunbar Bev Harpell with the assistance

More information

Latest Guidelines for Lipid Management

Latest Guidelines for Lipid Management Latest Guidelines for Lipid Management Goals Recognize the differences between different guidelines Understand the effective strategies to tailor lipid lowering therapies based on evidence and guideline

More information

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

Association between arterial stiffness and cardiovascular risk factors in a pediatric population + Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro

More information

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic

More information

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine

More information

Study of serum Lipid Profile patterns of Indian population in young Ischaemic Heart Disease

Study of serum Lipid Profile patterns of Indian population in young Ischaemic Heart Disease Original article: Study of serum Lipid Profile patterns of Indian population in young Ischaemic Heart Disease Dr Sonu Yadav, Dr Abhijit Nikam, Dr Vivek Chiddarwar, Dr A L Kakrani Department of Medicine,

More information

Case Study: Chris Arden. Peripheral Arterial Disease

Case Study: Chris Arden. Peripheral Arterial Disease Case Study: Chris Arden Peripheral Arterial Disease Patient Presentation Diane is a 65-year-old retired school teacher She complains of left calf pain when walking 50 metres; the pain goes away after she

More information

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized

More information

Diabetologia 9 Springer-Verlag 1991

Diabetologia 9 Springer-Verlag 1991 Diabetologia (1991) 34:590-594 0012186X91001685 Diabetologia 9 Springer-Verlag 1991 Risk factors for macrovascular disease in mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease

More information

AUTONOMIC FUNCTION IS A HIGH PRIORITY

AUTONOMIC FUNCTION IS A HIGH PRIORITY AUTONOMIC FUNCTION IS A HIGH PRIORITY 1 Bladder-Bowel-AD Tetraplegia Sexual function Walking Bladder-Bowel-AD Paraplegia Sexual function Walking 0 10 20 30 40 50 Percentage of respondents an ailment not

More information

Cardiovascular Complications of Diabetes

Cardiovascular Complications of Diabetes VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary

More information

The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema

The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema Dept Cardiology, Leiden University Medical Center, Leiden,

More information

Prevalence of Cardiovascular Risk Factors in Indian Patients Undergoing Coronary Artery Bypass Surgery

Prevalence of Cardiovascular Risk Factors in Indian Patients Undergoing Coronary Artery Bypass Surgery Original Article Prevalence of Cardiovascular Risk Factors in Indian Patients Undergoing Coronary Artery Bypass Surgery RR Kasliwal*, A Kulshreshtha**, Sweta Agrawal**, M Bansal***, N Trehan+ Abstract

More information

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive

More information

PIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia

PIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia PIEDMONT ACCESS TO HEALTH SERVICES, INC. Policy Number: 01-09-021 SUBJECT: Guidelines for Screening and Management of Dyslipidemia EFFECTIVE DATE: 04/2008 REVIEWED/REVISED: 04/12/10, 03/17/2011, 4/10/2012,

More information

Epidemiology of Diabetes, Impaired Glucose Homeostasis and Cardiovascular Risk. Eberhard Standl

Epidemiology of Diabetes, Impaired Glucose Homeostasis and Cardiovascular Risk. Eberhard Standl Epidemiology of Diabetes, Impaired Glucose Homeostasis and Cardiovascular Risk Eberhard Standl European Heart House Sophia Antipolis Thursday, June 17, 2010 IDF Diabetes Atlas 2009: Global Numbers Still

More information

Original Article. Gautam A.G 1, Bansal P 2, Chauhan R 3, Chadha V 4 NTRODUCTION

Original Article. Gautam A.G 1, Bansal P 2, Chauhan R 3, Chadha V 4 NTRODUCTION Original Article A Prospective Study To Know Socio-Demographic Profile In Patients With Acute Coronary Syndrome Admitted At A Tertiary Health Care And Teaching Hospital In Himachal Pradesh, North India

More information

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen

More information

Downloaded from ijdld.tums.ac.ir at 19:13 IRDT on Friday May 4th 2018

Downloaded from ijdld.tums.ac.ir at 19:13 IRDT on Friday May 4th 2018 - : -. : - 3 *. () - :.. 30 608 43 : (LDL-C) (HDL-C) TG/HDL-)HDL-C TG (TC/HDL-C)HDL-C (HRs) TC (non- HDL-C) (TG) (TC) HDL. 8/4. HR. ( 98 9). TG/HDL-C (C 89 : HDL-C.[/3 (/0 -/57)] TC/HDL-C. ( C ) WHO non-hdl-

More information